Empowering Healthcare through People, Process,
& Technology
Providing reliable and consistent professional services to life science companies through all phases of drug development from Phase I to Market and Patient Access.
Transforming and Inspiring Excellence Through Specialized Services
Our Services
Program & Project Management
Providing project management expertise to effectively manage clinical studies, program and product launches, systems and process implementations, and change management including training.
Implementation Experts
Leveraging implementation experts with the knowledge, experience, and skills to partner with clients to implement and launch systems and processes to advance drug and therapeutics development.
Data Lifecycle Management
Integrating, managing, and harnessing the power of data to streamline information to ensure compliance, accuracy, completeness, security, timeliness, and accessibility.
Clinical Studies
Utilizing experienced Clinical Managers, In-house CRAs/CTAs, and Site Monitors to effectively execute and manage clinical trials.
Lab Professionals
Engaging laboratory experts to effectively conduct, process, analyze, and manage samples for research, testing and drug development.
Market & Patient Access
Navigating regulatory, reimbursement, and distribution pathways to maximize patient access while maintaining commercial viability.
About Us
Headquartered in McLean, VA and servicing clients nationwide, we are a team of professionals with over 35 years of combined life science experience. Our expertise span across the full lifecycle of drug, systems, and process development from clinical trials to market and patient access.
We understand the intricate challenges that are faced by the life science industry and deliver solutions that drive success!
Featured News
The Future Of Medicine: How AI Is Revolutionizing Pharma
The artificial intelligence (AI) revolution seems to pick up pace from one week to the next, but what does it mean for the pharmaceutical sector?
FDA panel makes the call on much-anticipated Alzheimer’s drug donanemab
A Food and Drug Administration advisory panel on Monday endorsed the experimental Alzheimer’s drug donanemab, which studies showed slowed early stages of the fatal mind-robbing
InnovationRx: Tarsus Pharmaceuticals Takes Aim At Disease-Causing Bugs
Around 25 million Americans are affected by the eye disease Demodex blepharitis, which is caused by small mites that make their way into the eyelid. This causes chronic
